Implantable Neurostimulation Devices Market

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Implantable Neurostimulation Devices Market contains market size and forecasts of Implantable Neurostimulation Devices in global, including the following market information:

Global Implantable Neurostimulation Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Implantable Neurostimulation Devices Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Implantable Neurostimulation Devices companies in 2021 (%)

The global Implantable Neurostimulation Devices market was valued at 6832.2 million in 2021 and is projected to reach US$ 13930 million by 2028, at a CAGR of 10.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Spinal Cord Stimulation (SCS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Implantable Neurostimulation Devices include Medtronic, Boston Scientific, St. Jude Medical (Abbott), LivaNova, Nevro, NeuroPace, Beijing Pins and Synapse Biomedical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Implantable Neurostimulation Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Implantable Neurostimulation Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Implantable Neurostimulation Devices Market Segment Percentages, by Type, 2021 (%)

Spinal Cord Stimulation (SCS)

Gastric Electric Stimulation (GES)

Deep Brain Stimulation (DBS)

Sacral Nerve Stimulation (SNS)

Vagus Nerve Stimulation (VNS)

Others

Global Implantable Neurostimulation Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Implantable Neurostimulation Devices Market Segment Percentages, by Application, 2021 (%)

Pain Management

Parkinson's Disease

Urinary and Fecal Incontinence

Epilepsy

Gastroparesis

Others

Global Implantable Neurostimulation Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Implantable Neurostimulation Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Implantable Neurostimulation Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Implantable Neurostimulation Devices revenues share in global market, 2021 (%)

Key companies Implantable Neurostimulation Devices sales in global market, 2017-2022 (Estimated), (Units)

Key companies Implantable Neurostimulation Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic

Boston Scientific

St. Jude Medical (Abbott)

LivaNova

Nevro

NeuroPace

Beijing Pins

Synapse Biomedical